Astellas Pharma Inc. - Total Cash From Operating Activities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Cash-From-Operating-Activities" stands at 243.23 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.

Astellas Pharma Inc.'s first quarter result of 55.85 Billion JPY for the item "Total Cash From Operating Activities" represents a decrease of -45.70 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of 55.85 Billion JPY for the item "Total Cash From Operating Activities" represents an increase of 343.27 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of 243.23 Billion JPY for the item "Total Cash From Operating Activities" represents an increase of 21.63 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 40.69 percent compared to the value the year prior.
The 1 year change in percent is 40.69.
The 3 year change in percent is -8.63.
The 5 year change in percent is 2.98.
The 10 year change in percent is 55.24.

The Serie's long term average value is 235.48 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 3.29 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 06/30/2025, is +383.06%.
The Serie's change in percent from it's maximum value, on 09/30/2021, to it's latest available value, on 06/30/2025, is -26.58%.